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ABSTRACT
Purpose: Worldwide there are nearly 1.1 million new cases of gynaecological cancer annually.
In England, uterine, ovarian and cervical cancers comprize the third most common type of
new cancer in women. Research with gynaecological cancer patients within 6 months of
diagnosis is rare, as is data collection that is roughly contemporaneous with treatment. Our
aim was to explore the experiences of women who were, at study entry, within 6 weeks of
surgery or were undergoing chemotherapy or radiotherapy. Methods: An interpretative
phenomenological analysis (IPA) of data from 16 women in five focus groups was conducted
in the UK, exploring women’s experiences of being diagnosed with and treated for gynae-
cological cancer. Results: Participants conceptualized their experiences temporally, from the
shock of diagnosis, through their cancer treatment, to thinking about recovery. They tried to
make sense of diagnosis, even with treatment being complete. In the context of the Self-
Regulation Model, these women were struggling to interpret a changing and multi-faceted
illness identity, and attempting to return to pre-illness levels of health. Conclusions: This
study adds to this under-studied time period in cancer survivorship. The results suggest that
survivors’ goals may change from returning to pre-illness status to reformulating goals as
survival time increases.
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Introduction
Gynaecological cancers impact the ovaries, uterus,
vagina, endometrium, vulva and fallopian tubes. These
cancers accounted for.3% of female cancers in 2012, with
nearly 1.1 million new cases annually worldwide (Ferlay
et al., 2015). Globally, cervical cancer was the fourth most
frequent cancer for women and had the highestmortality
rate of all female cancers, at 7.5% (Ferlay et al., 2015). In
England, uterine, ovarian and cervical cancer were the
third most common type of new cancer registered in
women, following on from breast and lung cancers
(Bannister, 2016). While gynaecological cancers make up
a significant proportion of female cancers, research on
survivorship is under-studied (Hughes, Whitford, Collins,
& Denson, 2014; Roberts & Clarke, 2009), especially in
comparison to breast cancer.
The experience of cancer involves dynamic, long-
term processes, where patient needs, focus and prio-
rities change over time (Fiszer, Dolbeault, Sultan, &
Brédart, 2014; Tariman, Doorenbos, Schepp, Singhal, &
Berry, 2014), especially as they move from being can-
cer patients to being cancer survivors (Sandsund,
Pattison, Doyle, & Shaw, 2013). Cancer removal is
prioritized for newly diagnosed patients, whereas
those surviving long-term (at least 5 years) may
begin re-evaluating life purpose and meaning (Sekse,
Raaheim, Blaaka, & Gjengedal, 2010). Additionally, sur-
vivors integrate past events into accounts of the pre-
sent (Roberts & Clarke, 2009), meaning that both time
point and cumulative experiences are important
aspects for consideration. While Hammer, Mogensen
and Hall (2009) conducted their research immediately
after diagnosis, most other work, both qualitative and
quantitative, has taken place some time after diagno-
sis or treatment, from 12 months post-surgery
(Roberts & Clarke, 2009), 5 years post-diagnosis (Reb,
2007; Sekse et al., 2010; Walton, Reeve, Brown, &
Farquhar, 2010) and up to 16 years post-diagnosis
(Molassiotis, Chan, Yam, Chan, & Lam, 2002). Whilst
temporal breadth is important, research is diffused
over a range of time points, with much occurring
well after original diagnosis. There is little research
that takes place within 6 months of diagnosis (e.g.,
Ekwall, Ternestedt, & Sorbe, 2003; Hammer, Hall, &
Mogensen, 2013; Hammer et al., 2009). One particular
gap in the time frame is that where women have
completed active treatment but are not yet officially
in remission from cancer. This makes this time point
an area ripe for additional, explorative, qualitative
research.
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Previous research, both quantitative and qualitative,
has investigated distress and mental health disorders in
gynaecological cancer patients (Reuter, Raugust,
Marschner, & Haertner, 2007; Stewart, Wong, Duff,
Melancon, & Cheung, 2001), as well as support
(Beesley et al., 2008; Ussher, Kirsten, Butow, &
Sandoval, 2006; Walton et al., 2010), informational
(Booth, Beaver, Kitchener, O’Neill, & Farrell, 2005) and
psychosocial needs (Miller, Pittman, & Strong, 2003;
Warren, Melrose, Brooker, & Burney, 2016).
Additionally, qualitative research has expanded to
explore the experience of cancer, particularly in relation
to topics such as hope (Hammer et al., 2013; Reb, 2007),
meaning (Akyüz, Güvenç, Üstünsöz, & Kaya, 2008;
Roberts & Clarke, 2009; Sekse et al., 2010), the impact
of childlessness or loss of fertility for younger women
(Molassiotis et al., 2002; Roberts & Clarke, 2009) and
changing family roles (Akyüz et al., 2008). Other topics
identified included uncertainty and risk (Roberts &
Clarke, 2009; Sekse et al., 2010), body image and sexual
function (Ekwall et al., 2003; Maughan, Heyman, &
Matthews, 2002; Molassiotis et al., 2002). Much of this
research has been at the intersection of individual
experience with healthcare providers, and often from a
nursing perspective (e.g., Ekwall et al., 2003; Reb, 2007;
Roberts & Clarke, 2009; Walton et al., 2010), without
drawing on relevant psychological theory.
One theory that has appeared in gynaecological can-
cer research is the self-regulationmodel (SRM) (Leventhal
et al., 1997). The SRM is often described as a common
sense model of illness experience and combines multi-
dimensional illness representations, goals formulated in
response to the health threat, and coping strategies
(Leventhal, Leventhal, & Contrada, 1998). It is a concep-
tualisation of a health problem that models a cyclical
process through goal setting, coping strategy selection
and implementation, and then evaluation and readjust-
ment (Boekaerts, Maes, & Karoly, 2005). The SRM is a good
fit with qualitative research into health experiences
because it is essentially phenomenological (Leventhal
et al., 1998), thus meshing well with qualitative
approaches such as interpretative phenomenological
analysis (IPA) (Smith, 1996). IPA and the SRM have been
combined to study varioushealth issues including inferti-
lity (Phillips, Elander, & Montague, 2014), early stage
dementia (Harman & Clare, 2006), non-epileptic seizures
(Green, Payne, & Barnitt, 2004) and vitiligo (Thompson,
Kent, & Smith, 2002). Bruner and Boyd (1999) used the
SRM as a conceptual framework for developing a sexual
functioning measure. Bradley, Calvert, Pitts and Redman
(2001) applied it to their research with gynaecological
cancer patients, focusing on illness identity linked with
the circumstances of diagnosis and its impact on future
evaluations of cancer recurrence. The elements of the
SRM are valuable concepts in interpreting experiences
and their impact, and in combination with IPA as a
phenomenological approach.
Most qualitative gynaecological cancer research
has used interviews, which give a particular perspec-
tive. Turning to other forms of data collection, such as
focus groups (FGs) (Ussher et al., 2006), may illumi-
nate different aspects of experience, particularly add-
ing to our understanding of how social contexts
might influence illness representations. The aim of
the present study was to explore the experiences of
women who had received treatment for gynaecologi-
cal cancer, but are not yet officially in remission.
Methods
Five FGs explored the experience of living with gynae-
cological cancer. The data were analysed using IPA,
which investigates how people make sense of health
experiences. As an experiential model of health and
illness, the SRM is a good fit with phenomenological
approaches such as IPA (Smith, Flowers, & Larkin,
2009). While IPA has been traditionally problematic
for analysing FG data, recent methodological sugges-
tions provide a basis for carrying out this kind of
analysis (Palmer, Larkin, de Visser, & Fadden, 2010;
Tomkins & Eatough, 2010). Taking account of difficul-
ties, and building on work cited above, we developed
our own analysis approach, which is described later in
this article (Phillips, Montague, & Archer, 2016).
Participants
Sixteen women (age range 31–79 years; mean age 60)
who had participated in a yoga intervention took part in
these FGs. The participantswere a subset of a larger study
of women being treated for gynaecological cancer
recruited from a large hospital in the UK. At the start of
the study, participants were either within 6 weeks of
surgery or were receiving chemotherapy or radiotherapy
for cancer of the ovary, cervix, vulva, uterus, fallopian
tube or peritoneum. Most still had to undergo their first
scan post-treatment but at the focus group the majority
had completed treatment. They all felt well enough to
participate in a programme of gentle yoga.
Data collection
Participants were invited to attend one of a series of
FG discussions facilitated by SA, and some with a yoga
instructor also participating (see Table 1). Focus
groups were conducted between June 2011 and
June 2012. The participants requested the instructors’
presence to allow them to give direct feedback about
programme-related components. The instructors only
participated in the discussion when directly
addressed. The FGs were guided by a range of open-
ended questions, such as the type of cancer, the
treatment they had, and their experiences around
health and illness, specifically about cancer. Each FG
2 E. PHILLIPS ET AL.
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was audio recorded and transcribed verbatim. All
names used here are pseudonyms. The study con-
formed to the British Psychological Society’s ethical
standards (British Psychological Society, 2009), and
participants were fully briefed on the purpose of the
discussion. The overall research project received NHS
Research Ethics Committee approval and local
Research & Development approval.
Analysis approach
Initially, transcripts were coded using a standard IPA
approach, noting how and where participants made
sense of their own experiences (Smith et al., 2009). All
aspects of the data were coded, spanning yoga, can-
cer and treatment. One set of themes, discussing the
yoga programme, was presented in a previous paper
(Archer, Phillips, Montague, Bali, & Sowter, 2015). We
then turned our attention to interactions and group
concepts. Each transcript was coded again, identifying
the ways in which participants made sense of their
world and their interactions with others, as well as
coding conversations between participants, where
they made meaning together.
During this process, we developed a model where
the individuals’ interpretations of their own experiences
lay at the centre, wrapped around by layers of widening
social contexts. We looked at how participants related
their accounts to those of other patients, other group
members, their social circle and the wider world. These
layers were used to interpret participants’ experiences in
the analysis presented here, concentrating on themes
that were prevalent among, and representative of
(Smith, 2011), the participating individuals.
Analysis
The women’s accounts of health and illness fell into a
temporal arc with three parts: (1) the shock of diag-
nosis (past), (2) having treatment to remove the can-
cer (mostly past) and (3) hoping for recovery (present
and future). These three themes encompass both sig-
nificant aspects of the women’s experience of cancer
and general ways of storytelling about their lives.
“Like being mowed down by a bus”: The
shock of diagnosis
In the early parts of their accounts, participants
described their diagnoses. Within these descriptions
they attempted to make sense of the suddenness and
seriousness of what happened, which often occurred
during regular check-ups:
I just went for a routine smear test in September and
they found I’d got a tumour. And I went to [name of
hospital] and they took a biopsy, and they told me
that it was cancerous, so then I got referred to [name
of hospital] where within 3 weeks I’d had a full hys-
terectomy [laugh] oh this was—I had to wait ‘til—I
found out on Christmas eve, actually, about it, that it
was cancerous and I’d got to wait over Christmas.
(Lucy, FG1)
Lucy’s account focused on practicalities—times and
places—and minimized the emotional impact of diag-
nosis while including dramatic contrasts: between a
“just. . .routine” test and the serious diagnosis; the
speed of some events, against a wait over Christmas.
Her laughter further reinforced these incongruities.
She had little time to become accustomed to the
idea of cancer before it was removed. Others reflected
on the shocking nature of their diagnosis:
I mean it’s such a traumatic experience, isn’t it?
Because you have to go through the day when they
say to you you’ve got cancer, and when you don’t
think you have, it didn’t even enter my head, the
shock was [pause] unbelievable, awful, and then
you’ve got to go through the MRI scan, you know,
the things like that, and all of that is traumatic, isn’t
it? (Lily, FG 2)
Where the time of year was significant for Lucy, Lily’s
description of “the day. . .you’ve got cancer” gave a
precise time-point where cancer started for her. She
Table 1. Focus-group participants.
Participant name Age Cancer Stage Treatment
Focus group 1 Liz 55 Ovarian Stage 3 Surgery/chemo
Kathleen 68 Primary Peritoneal Stage 3 Chemo
Lucy 32 Cervical Stage 2 Surgery/radio
Alice 57 Ovarian Stage 3 Surgery/chemo
Sheila 63 Endometrial Stage 3 Surgery/radio
Focus group 2 Helen 61 Endometrial Stage 1 Surgery
Brenda 79 Endometrial Stage 1 Surgery/Radio
Lily 77 Endometrial Stage 1 Surgery
Focus group 3 Brenda 79 Endometrial Stage 1 Surgery/radio
Sharon 63 Ovarian Stage 4 Surgery/chemo
Rose 56 Endometrial Stage 1 Surgery
Focus group 4 Moira 52 Ovarian Stage 1 Surgery/chemo
Jane 69 Endometrial Stage 1 Surgery/radio
Betty 65 Endometrial Stage 1 Surgery
Focus group 5 Dorothy 56 Endometrial Stage 1 Surgery
Sheena 64 Ovarian Stage 1 Surgery/chemo
Judith 57 Endometrial Stage 1 Surgery
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described the shock and trauma associated with diag-
nosis, which the pause emphasized, as did other par-
ticipants (for example Alice (FG1) mentioned
“incredible lows” and “shocks”). Lily’s account
switched between “we”, “you” and “I”, which, along
with the tag question (Lakoff, 2004) “isn’t it” that
peppered her account, oriented her experience to
that of the other women present. She attributed
these reactions to all, assuming them as common
across the group. Accounts of diagnosis, therefore,
showed a contrast between conveying neutral facts,
possibly even a dramatic, exciting story, and clearly
apparent trauma and devastation.
For many participants, cancer had few identifiable
symptoms, and left them trying to interpret their
serious diagnosis against a background of having
not felt ill:
Moira: I didn’t have a definite diagnosis until after
the operation. I’d just gon-, I’d gone to the
GP for something else because I was well
having pains here and he just looked at me
and said there’s a lump there [laughs] I had
no idea. How can you =
Jane: = I had no pain anywhere =
Moira: = how can you not notice something like
that [laughs]?
Jane: And I didn’t lose weight or anything like that
and so you know there were no pointers to
say there was anything wrong, until a very
slight bleed. (FG 4)
Moira and Jane co-constructed an account, sug-
gesting a similar experience and showing a disso-
nance that many participants also struggled to
understand between their sense of embodiment and
the cancer diagnosis. Underlying this were ideas
about what it “should” mean to have cancer: that it
was expected to be associated with symptoms like
weight loss, pain and feeling ill. Their experience did
not fit with their expectations of what cancer should
be. These ideas were reinforced by others’ opinions
on what they expected to see in those with cancer:
Brenda: And when you meet people out and they
say have you really, you don’t look as
though you’ve been, and they say you
don’t look as though you’d been ill, but
I’ve never felt ill.
Rose: Yeah, that’s the same as me I’ve never felt
ill at all, really.
Sharon: Well, I felt very very ill when I first started,
didn’t suspect anything like cancer, I must
admit, but I was really really ill and prob-
ably didn’t realize quite how ill I was. (FG 3)
Not only did participants not necessarily feel ill,
but, as Brenda highlighted, they did not always
appear so to others. Some did feel unwell before
diagnosis, however, and Sharon’s differing experience
emerged during this exchange. In contrast to Brenda
and Rose’s stories, Sharon emphasized how “very” and
“really” ill she was. Even though she felt differently,
however, this was still not associated with cancer.
Being bound together by their illness and highlight-
ing commonalities where they existed (such as none
of them suspecting cancer) indicates a level of secur-
ity with one another in recounting their experiences.
The cancer experience started suddenly for most
participants, with diagnosis being a surprise, and
few symptoms to indicate the possibility of some-
thing serious. The women tried to make sense of
what cancer meant for them, especially the lack of
symptoms and not feeling (or looking, according to
others’ reports) ill at all. There was disruption to
routine, particularly when their diagnosis occurred
during a medical consultation for a seemingly mun-
dane issue. The women demonstrated two distinc-
tive ways of talking about their disease, as either a
factual account, or one that foregrounded the shock
and horror of cancer. Following diagnosis, the
women discussed their next significant time point
as that of treatment.
“You’ve taken it away, I haven’t got it now!”:
What is treatment?
Treatment was discussed less frequently within the
groups than diagnosis or recovery, perhaps because
the women had been in contact during treatment
while participating in the yoga programme, and
were therefore more familiar with each other’s experi-
ence at that time. Participants made some unex-
pected interpretations of what they considered
treatment to be, however:
Betty: I’m Betty. I’ve had ovarian
cancer and I’ve not had
any treatment, have I?
Janine (Betty’s daughter): You’ve had a full
hysterectomy.
Betty: Sorry?
Janine: Full hysterectomy. (FG 4)
Betty sought clarification about her treatment and
her daughter, Janine, located her hysterectomy within
this category. It was unclear how Betty interpreted her
surgery: perhaps because as hysterectomy occurs
among this age group for other conditions, she
might not have perceived it as specific to her cancer.
For others, not having had surgery required
explanation:
So it hadn’t actually affected any of the organs as
such, but there was no operation I could have. I had a
biopsy by through having laparoscopy and all this so
called seeding, which is tiny little cancerous cells
inside the momentum [sic], the only way to cure it
really was by purely chemo, so I’ve had 6 doses of the
chemo, which was exactly the same treatment as you
4 E. PHILLIPS ET AL.
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have for ovarian cancer, the taxol and the carbonpla-
tin with all the side effects [laughs]. (Kathleen, FG 1)
The phrase “no operation I could have” emphasized
surgery as not available for Kathleen, rather than not
needed. This suggests that requiring surgery may give
validity to her diagnosis, and normalize her experi-
ence to other participants, whose treatment pro-
gramme was surgery then chemotherapy and/or
radiotherapy. Kathleen highlighted receiving “purely
chemo”, using drugs’ names without explanation and
noting similarities in treatment protocols and side-
effects. This emphasized experience shared with the
group and established her group membership.
In contrast with the lack of symptoms prior to
diagnosis, participants expected and found that treat-
ment would cause patients to “feel ill” (Lily, FG 2) and
generally treatment caused more physical effects than
existed prior to diagnosis:
Well, from a radiotherapy point of view it was, it was
severe fatigue but it wasn’t, you did want to go to
sleep but it was such a heavy eyed feeling that every-
where you were, either on your feet or sitting down,
you just wanted to shut your eyes, you know, and it
was such a fatigue type, a draining feeling. And the
only other side-effect I had was nausea, but they did
give me some tablets, which helped, but it never
actually went away and it was there all the while.
(Sheila, FG1)
Sheila minimized her side-effects from radiotherapy,
highlighting severe fatigue and nausea as being the
only ones she experienced. These affected her differ-
ently: she was weighed down by the exhaustion asso-
ciated with radiotherapy, emphasized by phrases like
feeling “heavy eyed” and it being “draining”. In com-
parison, the nausea she experienced appeared less
bothersome and was somewhat treatable. Unlike
most participants, Sharon had emphasized feeling
extremely ill before diagnosis (see quote in previous
section), and treatment improved her well-being in
comparison:
But once I started having the treatment then I got
better and better and you know, I feel I’ve done really
well through the treatment and operation and every-
thing, compared to how, well about this sort of time
last year when it first started. (Sharon, FG 3)
Sharon felt she had underestimated her illness and
indicated surprize at how much better she felt once
treatment started. In comparison, most other partici-
pants had not felt ill, and most of their discomfort
with cancer arose during treatment and due to those
side-effects. Health at diagnosis was a key comparison
for evaluating the side effects of treatment, and later
recovery.
The women discussed treatment less than diagno-
sis or recovery, perhaps because it was something
they were not in control of; they were following a
protocol they were given to achieve their goal of
having the cancer removed. While diagnosis was still
significant to the participants, treatment appeared
less so. Surgery was not necessarily considered treat-
ment, although the women tried to highlight the
aspects they had shared. While many found cancer
itself largely symptom free, treatment caused many
side-effects. The significance of side-effects, and the
perception of what treatment entailed, were impor-
tant elements in how participants made sense of it.
These also affected the trajectory of the women’s
recovery.
“Touch wood, hopefully, everything will be
alright”: Defining recovery
Most participants had finished treatment whilst parti-
cipating in the yoga intervention and their accounts
were focused on recovery. Many described having
had cancer but having been cured, particularly during
introductions, with factual statements such as “I had
endometrial cancer” (Sheila, FG 1) and “I’ve had ovar-
ian cancer, which was removed” (Moira, FG4). The
latter, in particular, positioned cancer as over, but
defining recovery was not always as straightforward:
As far as I’m concerned it’s gone, the surgeon says it’s
gone, so I hope that that is right. (Jane, FG 4)
Jane cited medical opinion and authority to define
her recovery and surgery as an important marker for
treatment. Despite stating her surgeon’s assessment
of her cancer she demonstrated a glimmer of doubt,
suggesting that shedding the label of cancer required
further confirmation. For others, recovery meant get-
ting back to normal:
Rose: I think what surprised me is, at first I sort of
really well, everybody couldn’t believe how
well I was doing, but I wasn’t doing any-
thing I was resting, walking =
Brenda: = Yes, that’s what I found =
Rose: = You know, sort of like, so I’d hardly got
any pain or anything but then it’s when a
few months after, when you start doing
stuff you think well should it be hurting
now? You know, and I think it’s the fact
that, well the doctor said it sort of takes
up to a year to get back to normal. (FG3)
Recovery occurred in stages, starting with feeling
well and not feeling pain, basic mobility and then
resuming pre-cancer roles and activities, essentially
returning to “normal”, which was the goal of partici-
pants. As Rose described above, the expected timeline
for recovery was not clear. They gleaned information
from their doctors, observations of others, pain
experience and reactions to medication, among
other things. As with the cancer label, participants
viewed their recovery through the eyes of family
and friends, which was not always helpful, as others’
INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING 5
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perceptions did not necessarily mesh with partici-
pants’ views of their own capabilities and situation:
Your friends and your family are, you know, the sort
of, the sympathy bucket is only so big, isn’t it? And
after you’ve, you know, you’ve physically seem to
have recovered and you can do pretty much all the
things that you always did before, people forget,
which is absolutely right, healthy and proper. They
forget that you’ve been very poorly or potentially
even may be poorly again. (Judith, FG5)
Participants may be seen by others as being fully
recovered when they are not; similarly, others may
remain unaware of future challenges, again, causing
a clash of perceptions. For Judith, support from others
was tied to receiving “sympathy”, whereas from the
other participants, support entailed sharing common
experiences. Physical concerns for the future related
to getting back to previous activity, and emotional
dimensions centred on the uncertainty and worry
associated with future tests that others described:
And I think there’s a fear. I think there’s a great fear
that I’m sure we’ve all experienced that [yeah]. A fear
of the unknown, really, because, yes we are in a
fortunate position, we go for scans; but as the
appointment comes for my next scan, which is com-
ing very very soon, I know, I’m really hoping that, you
know, I could put my yoga experience things with the
breathing and the relaxation into practice because I
know I will be very worried. (Sheila, FG 1)
Appreciation of the available monitoring was
balanced by the anxiety it generated. As in the diag-
nosis stage, worry and anxiety seemed easily attribu-
ted to the whole group. Sheila generalized this fear to
other participants, contrasting with an earlier, perso-
nalized statement in the discussion that she “felt very
good, to be honest”. Including “to be honest” indi-
cated caution about statements of recovery (Edwards
& Fasulo, 2006), being sensitive to others recovering
more poorly, or not at that stage in treatment.
Recovery was, perhaps not unexpectedly, an area
of key importance to participants. Defining recovery
was difficult; it may have included receiving an official
statement of remission from the medical team,
appearing well to friends and family and regaining
old roles and engaging in old activities. In addition,
there was no clear point at which recovery had (at
least for these women) been achieved, and good
health, even from a medical standpoint, was condi-
tional and could be lost with future scans. This uncer-
tainty stood in contrast to the suddenness and
definiteness of diagnosis. The cycle of test and answer
led to worry and stress, and reliance on hope for the
future, because even clear statements from doctors or
scans appeared somewhat equivocal. The participants
were aware of the range of others’ experiences and
framed their accounts of their own recovery to be
considerate to these.
Discussion
The women’s experiences of gynaecological cancer
described a temporal arc from recollections of the
shock of diagnosis, through having their (mostly com-
plete) treatment to remove the cancer and projecting
hope for recovery into the future. There were fewer
accounts of treatment than of diagnosis and recovery,
and treatment seemed less troubling to the women,
with their accounts focusing largely on physical side-
effects. Other research has suggested that the main
need of cancer patients at diagnosis is to have the
cancer removed (Hammer et al., 2009), with surgery
the only treatment deemed curative by patients (e.g.,
Ekwall et al., 2003). As these women had mostly fin-
ished treatment, this stage was, perhaps, of less rele-
vance to them; as many said, the cancer had been
removed. This might also reflect the self-selection of
participants as able to take part in the yoga pro-
gramme during treatment, so while this experience
is likely not representative of all gynaecological cancer
patients, it shows that the range of experiences can
be large and some may feel stronger and more phy-
sically capable, despite the effects of treatment.
Many issues that our participants struggled with fit
the illness identity (label and symptoms of illness)
portion of the self-regulation model (Leventhal et al.,
1998), echoing findings from Bradley et al. (2001).
Participants emphasized the shock of diagnosis
(Akyüz et al., 2008; Leal et al., 2015), particularly
when they had experienced few symptoms, as is
common with gynaecological cancers, which are
often asymptomatic or attributed to other issues
such as irritable bowel syndrome or ageing (Goff,
Mandel, Melancon, & Muntz, 2004). There is a percep-
tion that cancer “should” be signalled by serious
symptoms (Bradley et al., 2001), as the women here
described, meaning there is a contradiction between
that label and the lack of symptoms; this enriches our
understanding of gynaecological cancer representa-
tions within the context of the SRM (see Leventhal
et al., 1998). Bradley et al. (2001) linked their partici-
pants’ illness identity to the symptoms they experi-
enced at diagnosis, projecting this forward to explain
anxiety about future recurrence. Our women
struggled with this issue, too, and also tried to recon-
cile input from various sources that went to create
that label. For example, a doctor may have told them
that the cancer was removed, but they were still
awaiting confirmatory scans. Their own sense of
embodiment could not identify cancer, and others’
perceptions of their illness (or lack of it) were another
source of uncertainty. The variety of sources providing
observations contribute to complexity of the “cancer”
label as an illness representation in the SRM.
The SRM includes concepts of time within illness
representations (Maes & Karoly, 2005). While diagnosis
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D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 D
erb
y]
 at
 07
:51
 07
 Se
pte
mb
er 
20
17
 
was a clear and memorable time point, the women
noted the uncertain timeline of their recovery;
another part of illness representations in the self-reg-
ulation model (Leventhal et al., 1998). The women
mentioned unexpected delays in returning to pre-ill-
ness levels of mobility and function and difficulty
knowing when these would return. Comparisons
with other research where participants were later on
in survivorship suggests that recovery goals may
change over time from a desire to return to pre-illness
function to trying to find a “new normal” (Molassiotis
et al., 2002; Reb, 2007; Sandsund et al., 2013). This
potential for changing goals in the time period after
treatment could benefit from further investigation. In
addition, this suggests a disconnect between expecta-
tions and actual recovery, which could benefit from
better understanding and communication to patients.
Some women in our study mentioned that informa-
tion from participants “further on” in the recovery
process was helpful. This kind of informational/experi-
ential support from other patients has been found to
be helpful in other areas of women’s health, such as
infertility (Malik & Coulson, 2008; Phillips, Elander, &
Montague, 2014). This illustrates the value of using
IPA to develop insights into the application of the
SRM with particular conditions.
One significant difference between this study and
much other cancer research is that data collection was
roughly contemporaneous with treatment. For the
women in this study, these were recent experiences,
whereas many studies took place much later, from
12 months post-surgery (Roberts & Clarke, 2009) to
up to 16 years post-diagnosis (Molassiotis et al., 2002),
in which time, narratives will almost certainly become
reconstructed as they are told and retold (Smith,
1994). Additionally, the potential for changing health
goals over time, with a “new normal” being created,
suggests that better understanding is needed of these
developments, particularly as this changing need may
require support from healthcare professionals and
those in support roles. Additional research is required
to investigate this in order to better address changing
patient needs over time.
There are aspects from previous gynaecological can-
cer research that did not emerge here. This can perhaps
be attributed to the effect of being in a group, or
because the group was in the context of a yoga pro-
gramme, within which context some topics were not
deemed appropriate. The women did not discuss the
possibility of death, for example, and there was no
discussion of marital difficulties or sexual problems,
which have occurred in other work (Reb, 2007; Roberts
& Clarke, 2009). Sekse et al. (2010) point out that topics
like death and sexuality are difficult to discuss, even in a
group of survivors, although they found a similar unspo-
ken understanding within their participant groups to
that which emerged here. The shared experiences
reported here reflect what Ussher et al. (2006) found:
that support groups enable community, acceptance and
sharing of information. Their reflections on the experi-
ence of all these stages of their diagnosis, treatment and
recovery demonstrate their importance to these partici-
pants, whatever the context. Healthcare professionals
and other support staff should be aware of the range
of patients’ experiences, and that not all individuals may
experience the same concerns or trajectory post-treat-
ment. Professionals should be sensitive to patients’
(potential lack of) willingness to discuss particular topics
within groups and provide appropriate environments to
do so.
This research explored participants’ experiences of
gynaecological cancer shortly after treatment. There is
little research with cancer patients in this time period,
and no work with this group conducted in the past
5 years that we were able to identify. Comparing this
study with other research findings suggests that post-
cancer experiences may evolve with time, and survi-
vors may experience a change from attempting to
regain their pre-diagnosis norm to attempting to
find a new goal and equilibrium. The themes showed
experience as a temporal arc that began with a shock-
ing diagnosis, but extended for an uncertain amount
of time into the future. Many of the issues addressed
fell into the concept of illness identity from the SRM,
showing participants struggling to make sense of
their cancer label. Contradictory messages from dif-
ferent members of their medical team, their own
embodied sense and observations of others obscured
where the illness could and should begin and end.
The SRM provides a valuable model and further work
on other aspects of the SRM, such as timeline and
changing goals, could be fruitful.
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